Spectrum Pharmaceuticals Inc expected to post a loss of 25 cents a share - Earnings Preview

Spectrum Pharmaceuticals

10/08/2021 21:01

* Spectrum Pharmaceuticals Inc  SPPI.OQ   SPPI.O  is expected
to show a no change in quarterly revenue when it reports
results on August 12. 
​* Refinitiv's mean analyst estimate for Spectrum
Pharmaceuticals Inc is for a loss of 25 cents per share. For the
same quarter last year, the company reported a loss of 28 cents
per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Spectrum
Pharmaceuticals Inc is $8​, about 67.9% above​ its last closing
price of $2.57. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021  -0.30       -0.31      -0.25     Beat    20.6
 Dec. 31 2020              -0.29      -0.29     Met     0
 Sep. 30 2020  -0.35       -0.35      -0.37     Missed  -5.7​
 Jun. 30 2020  -0.29       -0.32      -0.28     Beat    11.4
 Mar.          -0.34​      -0.35      -0.36     Missed  -4​
 31​ 2020​                                              
 Dec. 31 2019  -0.33       -0.33      -0.35     Missed  -7.4​
 Sep. 30 2019  -0.36       -0.41      -0.23     Beat    44.6
 Jun. 30 2019  -0.32       -0.27      -0.23     Beat    16.1
 This summary was machine generated August 10 at 20:01 GMT.  All
figures in US dollars unless otherwise stated